Increased concentrations of interleukin 1 beta, interleukin-2, and soluble interleukin-2 receptors in endoscopical mucosal biopsy specimens with active inflammatory bowel disease
about
Molecular mechanism of interleukin-2-induced mucosal homeostasisRole of serotonin on the intestinal mucosal immune response to stress-induced diarrhea in weaning miceChronic colitis in IL-10-/- mice: insufficient counter regulation of a Th1 response.Recent advances in inflammatory bowel disease.Interleukin 2 and interferon-gamma augment anticolon antibody dependent cellular cytotoxicity in ulcerative colitis.Increased group II phospholipase A2 in colonic mucosa of patients with Crohn's disease and ulcerative colitis.Selective inhibition of fatty acid oxidation in colonocytes by ibuprofen: a cause of colitis?Increased interleukin 8 expression in the colon mucosa of patients with inflammatory bowel disease.Changes of the mucosal n3 and n6 fatty acid status occur early in the colorectal adenoma-carcinoma sequenceNucleoside-nucleotide free diet protects rat colonic mucosa from damage induced by trinitrobenzene sulphonic acid.IL-1β suppresses innate IL-25 and IL-33 production and maintains helminth chronicity.Selective modulation of autophagy, innate immunity, and adaptive immunity by small molecules.Interleukin-1 associations in inflammatory bowel disease and the enteropathic seronegative spondylarthritis.Increased secretion of pro-inflammatory cytokines by circulating polymorphonuclear neutrophils and regulation by interleukin 10 during intestinal inflammationExpression of lymphocyte-endothelial receptor-ligand pairs, alpha4beta7/MAdCAM-1 and OX40/OX40 ligand in the colon and jejunum of patients with inflammatory bowel diseaseMucosal 5-aminosalicylic acid concentration inversely correlates with severity of colonic inflammation in patients with ulcerative colitis.Persistence of local cytokine production in shigellosis in acute and convalescent stages.Cytokines in inflammatory bowel disease.Role of interleukin-1 in the pathogenesis of experimental shigellosis.Imbalance of the interleukin 1 system in colonic mucosa--association with intestinal inflammation and interleukin 1 receptor antagonist [corrected] genotype 2.Changes in human mucosal gamma delta T cell repertoire and function associated with the disease process in inflammatory bowel disease.Soluble interleukin-2 receptors in ulcerative colitisHepatocyte nuclear factor 4alpha in the intestinal epithelial cells protects against inflammatory bowel diseasePlasma cytokine profiling in sibling pairs discordant for autism spectrum disorderThe role of cytokines in inflammatory bowel disease.Rate of occurrence and pathogenic effect of enteroaggregative Escherichia coli virulence factors in international travelers.Lymphocyte and macrophage interleukin receptors in inflammatory bowel disease: a more selective target for therapy?Intestinal permeability.Cyclosporin for inflammatory bowel disease: mechanisms and possible actions.Immunogenetics of cytokines. Relevance for future research on inflammatory bowel disease.A unifying hypothesis for the mechanism of NSAID related gastrointestinal toxicity.The influence of cigarette smoking on cytokine levels in patients with inflammatory bowel disease.Biological significance of soluble IL-2 receptor.Topical rosiglitazone treatment improves ulcerative colitis by restoring peroxisome proliferator-activated receptor-gamma activity.Polarised interleukin 8 secretion by HT 29/19A cells.Induction of NGAL synthesis in epithelial cells of human colorectal neoplasia and inflammatory bowel diseases.Cytokine tissue levels as markers of disease activity in pediatric Crohn disease.Anti-inflammatory role of interleukin-15 in Crohn's disease.Tumor necrosis factor alpha reduces butyrate oxidation in vitro in human colonic mucosa: a link from inflammatory process to mucosal damage?The proportion of Th1 cells, which prevail in gut mucosa, is decreased in inflammatory bowel syndrome.
P2860
Q24610882-54CA1812-C5CE-43A2-9D78-1C46EB84950EQ33820238-9DFD7648-B844-4438-8CDE-EE28F85C8AFFQ33867180-33179BA9-BF47-47C5-B06C-CBB5E86F137DQ34188405-891608D4-0579-45CC-99EA-2F8CB087064CQ34377018-34456CE6-0DAB-4441-8479-41D1E15A98DAQ34381740-C6EF01A7-E7E4-40F4-83BA-024790E4F066Q34407441-874ABA58-0744-4888-9848-551A2A9255BBQ34409290-E30B45B2-54A3-4EA4-BD4E-E753DEE8333CQ34409322-7166637D-C6F9-45B3-A7D3-2AFE69958C9EQ34410367-D46DD1E5-E1BD-4A4D-8DBE-5D27B7D4827AQ34916928-FA37972C-DA11-4635-9377-92A51723DB55Q35028145-BDE40577-9818-4ED4-A6C8-7B96422FA1CBQ35309145-8632329B-5A8E-44D0-BDB1-37B067FA69B5Q35350454-C2830F53-DEEF-45CF-84D0-5A376D848C9BQ35357996-6F698CA3-3769-46CD-9B62-8DF5229C1B13Q35361187-DCFB3E89-9307-4948-9110-D83770DEA10AQ35380946-4FA939CF-644A-4BDD-9EE7-E767EC245A52Q35556914-31C4FCFC-A0AF-44AD-A6C9-10D9DE707592Q35752669-B5C4F8B8-B026-4530-894B-6C7539ABF548Q35841247-95EA4016-8FF5-4B08-B822-D725B3671819Q36437700-7B73F877-BC75-4A5D-9FE7-465AB333752BQ36627074-99629795-31EF-4AA4-8875-43D795A9F983Q36732009-12972710-7655-4322-8AD5-EC6D39431475Q36741348-386989D5-7617-4DA4-A76E-5432F8BF3445Q37160344-C975A06A-8451-4563-BA77-E2E050D113B7Q39695148-5FA3BAAD-48F1-42A5-8D5A-72AF068239D2Q40690714-53CDEEDA-D851-4E7E-9B63-7AB202AB085EQ40723914-2D1A92D0-FAA4-4F17-98A1-427F9D696D9EQ40793055-C683FB9B-9939-44D4-9E42-861F5A20B546Q40963119-DF132E06-A74D-42BE-B4DB-7DC1EB805A3DQ41057440-4BEB3CB2-DF43-4F1C-B9A2-81045B3F12E9Q41666854-71973B01-7934-4871-8435-318E396B61CDQ42106899-93373471-E8E5-41DD-9ABB-AACD0817B0DAQ43189281-D2C52FD6-D8AA-44DF-A575-ADD72C3885E1Q43213463-7BFBE085-5275-4BE9-ADCC-60EC817EB1B5Q43226113-944EC120-82F0-48B6-BA53-E9F8C8EF6FE6Q43869172-1050AC0F-72C3-4C77-AB90-1EDF58D91CF0Q45285888-3C04A9EE-3450-4247-AC9B-3E209C1285D7Q46500048-72BB45AE-3AA6-4419-AF6E-9EFA7B01F5D3Q49059277-AFEF8647-C27B-4541-BF84-4BA8A6B88FC6
P2860
Increased concentrations of interleukin 1 beta, interleukin-2, and soluble interleukin-2 receptors in endoscopical mucosal biopsy specimens with active inflammatory bowel disease
description
1992 nî lūn-bûn
@nan
1992 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
1992 թվականի հունվարին հրատարակված գիտական հոդված
@hy
1992年の論文
@ja
1992年論文
@yue
1992年論文
@zh-hant
1992年論文
@zh-hk
1992年論文
@zh-mo
1992年論文
@zh-tw
1992年论文
@wuu
name
Increased concentrations of in ...... ive inflammatory bowel disease
@ast
Increased concentrations of in ...... ive inflammatory bowel disease
@en
Increased concentrations of in ...... ive inflammatory bowel disease
@nl
type
label
Increased concentrations of in ...... ive inflammatory bowel disease
@ast
Increased concentrations of in ...... ive inflammatory bowel disease
@en
Increased concentrations of in ...... ive inflammatory bowel disease
@nl
prefLabel
Increased concentrations of in ...... ive inflammatory bowel disease
@ast
Increased concentrations of in ...... ive inflammatory bowel disease
@en
Increased concentrations of in ...... ive inflammatory bowel disease
@nl
P2093
P2860
P356
P1433
P1476
Increased concentrations of in ...... ive inflammatory bowel disease
@en
P2093
P2860
P356
10.1136/GUT.33.1.55
P407
P577
1992-01-01T00:00:00Z